Pim-3 as a potential predictor of chemoradiotherapy resistance in locally advanced rectal cancer patients

Approximately 30% of locally advanced rectal cancer patients might not benefit from chemoradiotherapy; however, the response to neoadjuvant chemoradiotherapy in these cases is difficult to predict. Pim-3 is a member of the provirus integration site for a moloney murine leukemia virus family of prote...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Rong-xin, Zhou, Zhong-guo, Lu, Shi-xun, Lu, Zhen-hai, Wan, De-sen, Pan, Zhi-zhong, Wu, Xiao-jun, Chen, Gong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700084/
https://www.ncbi.nlm.nih.gov/pubmed/29167471
http://dx.doi.org/10.1038/s41598-017-16153-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700084/
https://www.ncbi.nlm.nih.gov/pubmed/29167471
http://dx.doi.org/10.1038/s41598-017-16153-3

Ejemplares similares